Skip to main content
. Author manuscript; available in PMC: 2022 May 1.
Published in final edited form as: Auton Neurosci. 2021 Mar 11;232:102796. doi: 10.1016/j.autneu.2021.102796

Figure 9: ETB receptor blockade does not alter blood pressure lability or ratio of true:non-baroreflex sequences in ETB-def and TG rats.

Figure 9:

A. Histograms of proportion of instances at a given SBP (number of instances of 10-second bins at each mmHg / total number of bins) during baseline and following 3–5 days of selective endothelin B antagonism with A-192621. Solid line represents mean ± 95% confidence interval. B. 24-hour average SBP at baseline and following A-192621. C. Range of SBP before and after A-192621. 2-way repeated measures ANOVA PA-192621 = 0.0130; Pgenotype = 0.0917; Pinteraction = 0.9112, with Sidak’s test for multiple comparisons. D. Standard deviation (SD) of SBP before and after A-192621. 2-way repeated measures ANOVA PA-192621 = 0.3368; Pgenotype = 0.0224; Pinteraction = 0.8057, with Sidak’s test for multiple comparisons. E. spontaneous baroreflex (sBRS) gain before and after 3–5 days of A-192621. 2-way repeated measures ANOVA PA-192621 = 0.3768; Pgenotype = 0.2905; Pinteraction = 0.8513, with Sidak’s test for multiple comparisons. F: ratio of true baroreflex sequences to non-baroreflex sequences during baseline and after A-192621. 2-way repeated measures ANOVA PA-192621 = 0.0969; Pgenotype = 0.0661; Pinteraction = 0.4078, with Sidak’s test for multiple comparisons.